ERBB2 and neoplasm: Evaluation of the nanoparticles' anticancer properties in in vitro and in vivo models showed that Da-PFC-NPs significantly inhibited TUBO breast cancer cell growth in a dose-dependent manner, while also inducing apoptosis in the tumor cells through caspase 3 and HER2 genes.